Runben Biotechnology Co., Ltd. (SHA:603193)
22.37
-0.18 (-0.80%)
At close: Mar 9, 2026
-29.72% (1Y)
| Market Cap | 9.05B |
| Revenue (ttm) | 1.52B |
| Net Income (ttm) | 305.33M |
| Shares Out | 404.59M |
| EPS (ttm) | 0.76 |
| PE Ratio | 29.47 |
| Forward PE | 26.84 |
| Dividend | 0.46 (2.04%) |
| Ex-Dividend Date | Sep 18, 2025 |
| Volume | 1,652,624 |
| Average Volume | 1,763,873 |
| Open | 22.36 |
| Previous Close | 22.55 |
| Day's Range | 22.08 - 22.43 |
| 52-Week Range | 21.93 - 44.00 |
| Beta | 0.02 |
| RSI | 35.69 |
| Earnings Date | Apr 23, 2026 |